Programs to optimize adherence in glaucoma

Optometry

Volumn 81, Issue 7, 2010, Pages 339-350

  Kowing, Dianne ^a,b   Messer, Dawn ^c,d   Slagle, Scott ^e,f   Wasik, Alyon ^g,h  

^a William Chappell Veterans Affairs Outpatient Clinic   (United States)

^b NOVA SOUTHEASTERN UNIVERSITY   (United States)

^c UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

^d SOUTHERN ARIZONA VA HEALTH CARE SYSTEM   (United States)

^e VETERANS AFFAIRS MEDICAL CENTER   (United States)

^f EDWARD VIA COLLEGE OF OSTEOPATHIC MEDICINE   (United States)

^g Southern Arizona Veterans Affairs   (United States)

^h SOUTHERN CALIFORNIA COLLEGE OF OPTOMETRY   (United States)

Author keywords

Adherence; Dosing aids and devices; Education; Electronic monitoring; Glaucoma

Indexed keywords

EYE DROPS;

ARTICLE; DRUG DELIVERY SYSTEM; EQUIPMENT DESIGN; GLAUCOMA; HUMAN; INSTRUMENTATION; INTERNET; METHODOLOGY; OPTOMETRY; PATIENT COMPLIANCE; PATIENT EDUCATION; REMINDER SYSTEM; VIDEORECORDING;

DRUG DELIVERY SYSTEMS; EQUIPMENT DESIGN; GLAUCOMA; HUMANS; INTERNET; OPHTHALMIC SOLUTIONS; OPTOMETRY; PATIENT COMPLIANCE; PATIENT EDUCATION AS TOPIC; REMINDER SYSTEMS; VIDEOTAPE RECORDING;

EID: 77953670624     PISSN: 15291839     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.optm.2009.09.021     Document Type: Article

References (33)

1. Friedman D.S., Hahn S.R., Gelb L., et al. Doctor-patient communication, health-related beliefs, and adherence in glaucoma results from the Glaucoma Adherence and Persistency Study. Ophthalmology 115 8 (2008) 1320-1327 7 e1-e3
2. Friedman D.S., Quigley H.A., Gelb L., et al. Using pharmacy claims data to study adherence to glaucoma medications: methodology and findings of the Glaucoma Adherence and Persistency Study (GAPS). Invest Ophthalmol Vis Sci 48 11 (2007) 5052-5057
3. Nordstrom B.L., Friedman D.S., Mozaffari E., et al. Persistence and adherence with topical glaucoma therapy. Am J Ophthalmol 140 4 (2005) 598-606
4. Robin A.L., and Covert D. Does adjunctive glaucoma therapy affect adherence to the initial primary therapy?. Ophthalmology 112 5 (2005) 863-868
5. Schwartz G.F. Compliance and persistency in glaucoma follow-up treatment. Curr Opin Ophthalmol 16 2 (2005) 114-121
6. The Advanced Glaucoma Intervention Study (AGIS). 7. The relationship between control of intraocular pressure and visual field deterioration: The AGIS Investigators. Am J Ophthalmol 130 4 (2000) 429-440
7. Kass M.A., Heuer D.K., Higginbotham E.J., et al. The Ocular Hypertension Treatment Study: a randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucoma. Arch Ophthalmol 120 6 (2002) 701-713 discussion 829-30
8. Leske M.C., Heijl A., Hussein M., et al. Factors for glaucoma progression and the effect of treatment: the early manifest glaucoma trial. Arch Ophthalmol 121 1 (2003) 48-56
9. Quigley H.A., and Broman A.T. The number of people with glaucoma worldwide in 2010 and 2020. Br J Ophthalmol 90 3 (2006) 262-267
10. Bramley T., Peeples P., Walt J.G., et al. Impact of vision loss on costs and outcomes in medicare beneficiaries with glaucoma. Arch Ophthalmol 126 6 (2008) 849-856
11. Stein J.D., Ayyagari P., Sloan F.A., et al. Rates of glaucoma medication utilization among persons with primary open-angle glaucoma, 1992 to 2002. Ophthalmology 115 8 (2008) 1315-1319 9 e1
12. Osterberg L., and Blaschke T. Adherence to medication. N Engl J Med. 4 353 5 (2005) 487-497
13. Ustundag C., Hermann M.M., and Diestelhorst M. Reliability of a New microprocessor-controlled compliance monitor. Invest Ophthalmol Vis Sci 46 (2005) ARVO E-abstract 4728
14. Hermann M.M., Ustundag C., and Diestelhorst M. Compliance with topical therapy after cataract surgery using a new microprocessor-controlled eye drop monitor. Invest Ophthalmol Vis Sci 46 (2005) ARVO E-abstract 3832
15. Kahook M.Y. Developments in dosing aids and adherence devices for glaucoma therapy: current and future perspectives. Exp Rev Med Devices 4 2 (2007) 261-266
16. Hollo G., and Kothy P. Can adherence to topical glaucoma medication be improved by using an audible alarm?: A pilot study. Pharm Med 22 (2008) 175-179
17. Kass M.A., Meltzer D.W., Gordon M., et al. Compliance with topical pilocarpine treatment. Am J Ophthalmol 101 5 (1986) 515-523
18. Okeke C.O., Quigley H.A., Jampel H.D., et al. Adherence with topical glaucoma medication monitored electronically the Travatan Dosing Aid study. Ophthalmology 116 2 (2009) 191-199
19. Ableson M., Torkildsen G., and Fink K. Taking steps toward better compliance. Rev Ophthalmol 13 2 (2006)
20. Robin A.L., Covert D., Novack G.D., et al. A comparison of adherence to glaucoma medical therapy for patients on one medication compared to two different medications using a computerized medications event monitoring system (mems) device. Invest Ophthalmol Vis Sci 48 (2007) ARVO E-abstract 5574
21. Patel S.C., and Spaeth G.L. Compliance in patients prescribed eyedrops for glaucoma. Ophthalmic Surg 26 3 (1995) 233-236
22. Ritch R., and Astrove E. A positioning aid for eyedrop administration. Ophthalmology 89 3 (1982) 284-285
23. Averns H., Hall J., and Webley M. Role of opticare eye drop delivery system in patients with rheumatoid arthritis. J Rheumatol 26 12 (1999) 2615-2618
24. Salyani A., and Birt C. Evaluation of an eye drop guide to aid self-administration by patients experienced with topical use of glaucoma medication. Can J Ophthalmol 40 2 (2005) 170-174
25. Walker R. Aids for eye drop administration. Pharm J 249 (1992) 608
26. Chang Jr. J.S., Lee D.A., Petursson G., et al. The effect of a glaucoma medication reminder cap on patient compliance and intraocular pressure. J Ocul Pharmacol 7 2 (1991) 117-124
27. Stack R.R., and McKellar M.J. Black eye drop bottle tips improve compliance. Clin Exp Ophthalmol 32 1 (2004) 39-41
28. Patil S., Reshetnikov S., Haldar M.K., et al. Surface-Derivatized nanoceria with human carbonic anhydrase II inhibitors and fluorophores: a potential drug delivery device. J Phys Chemistry C 111 24 (2007) 8437-8442
29. QLT Announces Encouraging Phase II Data from CORE Study Drug Delivery System. [Updated October 28, 2008; July 22, 2009]; Available at: http://www.drugs.com/clinical_trials/qlt-announces-encouraging-phase-ii- data-core-study-punctal-plug-delivery-system-5966.html. Last accessed January 25, 2010.
30. Gedde SJ. ALT reports positive 12-week results from trial punctal plug delivery system: OSN SuperSite; [Updated November 13, 2008; July 22, 2009]; Available at: http://www.osnsupersite.com/view.aspx?rid=32335. Last accessed January 25, 2010.
31. Non-invasive Measurement of Intraocular Pressure. [updated July 15, 2009; July 22, 2009]; Available at: http://www.onemedplace.com/database/list/cid/11301/. Last accessed January 25, 2010.
32. Ciolino J.B., Hoare T.R., Iwata N.G., et al. A drug-eluting contact lens. Invest Ophthalmol Vis Sci 50 7 (2009) 3346-3352
33. Kharod B.V., Johnson P.B., Nesti H.A., et al. Effect of written instructions on accuracy of self-reporting medication regimen in glaucoma patients. J Glaucoma 15 3 (2006) 244-247